Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SCT650C in Axial Spondyloarthritis
NCT06197009Phase 2Not yet recruiting
- Sponsor
- Sinocelltech Group Limited
- Start
- Jul 2024
- Primary completion
- Jul 2026
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of SCT650C in axial spondyloarthritis (axSpA), sponsored by Sinocelltech Group Limited. Planned start Jul 2024; status: not yet recruiting.
02
Drugs
SCT650C
03
Conditions
axial spondyloarthritis (axSpA)
Beyond the preview
Go deeper on NCT06197009.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06197009.